Cross Country Healthcare (NASDAQ: CCRN) reported Q2 EPS of $0.47, $0.07 better than the analyst estimate of $0.40. Revenue for the quarter came in at $331.83 million versus the consensus estimate of $297.34 million.

GUIDANCE:

Cross Country Healthcare sees Q3 2021 EPS of $0.30-$0.35, versus the consensus of $0.22. Cross Country Healthcare sees Q3 2021 revenue of $310-320 million, versus the consensus of $253.3 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.